Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco January DIC 600x60px
All >

News > Western Europe

Please find below news about Austria, Belgium, France, Germany, Liechtenstein, Luxembourg, Monaco, the Netherlands and Switzerland as well as about organisations from these countries.

Total search results: 11387 | Ordered by Date (descending)
1 2 3 ... 112 113 114  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Centogene AG. (12/10/18). "Press Release: Centogene and Chiesi Germany Sign Strategic Alliance in Lysosomal Storage Disorders". Rostock & Hamburg. 2018-12-10
Roche. (12/10/18). "Press Release: Changes to the Roche Corporate Executive Committee". Basel. 2018-12-10
Merck KGaA. (12/10/18). "Press Release: Merck and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models". Darmstadt. 2018-12-10
Gilead Sciences, Inc.. (12/10/18). "Press Release: Gilead Sciences Names Daniel O’Day Chairman and Chief Executive Officer". Foster City, CA. 2018-12-10
AC Immune S.A.. (12/7/18). "Press Release: In Memoriam – Dr. Andreas Muhs CSO, Scientific Leader and Friend Has Passed Away". Lausanne. 2018-12-07
Merck KGaA. (12/6/18). "Press Release: Merck in Agreement with Cyclica for AI-augmented Screening Platform to Expand Research Capabilities". Darmstadt. 2018-12-06
Abivax S.A.. (12/6/18). "Press Release: Abivax Receives DSMB Recommendation to Continue Ongoing Extension Study of Its Completed Phase 2a Clinical Trial in Ulcerative Colitis patients". Paris. 2018-12-06
Valneva S.E.. (12/6/18). "Press Release: Valneva and Hookipa Sign a Collaboration and Manufacturing Agreement". Saint-Herblain & Vienna. 2018-12-06
Qiagen N.V.. (12/6/18). "Press Release: Qiagen Announces New Collaboration to Develop Companion Diagnostic to Guide Treatment for Patients with PIK3CA-mutated Advanced Breast Cancer". Germantown, MD & Hilden. 2018-12-06
Alacris Theranostics GmbH. (12/4/18). "Press Release: Alacris Theranostics startet Seedmatch-Crowdfunding-Kampagne für einzigartige computergestützte Tumoranalyse zur Optimierung von Krebstherapien". 2018-12-04
Evotec AG. (12/4/18). "Press Release: Evotec and Leo Pharma Form Drug Discovery Alliance Targeting Dermatological Conditions". Hamburg & Ballerup. 2018-12-04
Domain Therapeutics S.A.. (12/4/18). "Press Release: Domain Therapeutics Signs a Multi-target Research Collaboration and License Agreement with Boehringer Ingelheim on G Protein-Coupled Receptors (GPCRs) for Central Nervous System Disorders". Strasbour 2018-12-04
Anagenesis Biotechnologies. (12/4/18). "Press Release: Anagenesis Biotechnologies Announces a €3 Million Investment by the Boehringer Ingelheim Venture Fund and Cap Innov’Est". Strasbourg. 2018-12-04
Biocartis Group N.V.. (12/3/18). "Press Release: Genomic Health and Biocartis Expand Collaboration to Urology with the Development of an Idylla Oncotype DX Genomic Prostate Score Test". Redwood City, CA & Mechelen. 2018-12-03
Argen-X N.V. (Argenx). (12/3/18). "Press Release: Argenx Provides Detailed Data from Phase 2 Clinical Trial of Efgartigimod in Immune Thrombocytopenia and Phase 1/2 Clinical Trial of Cusatuzumab in Acute Myeloid Leukemia". Breda & Ghent. 2018-12-03
Argen-X N.V. (Argenx). (12/3/18). "Press Release: Argenx Enters Exclusive Global Collaboration and License Agreement with Cilag GmbH International, an Affiliate of Janssen, for Cusatuzumab (ARGX-110)". Breda & Ghent. 2018-12-03
Selexis S.A.. (12/3/18). "Press Release: KBI Biopharma Inc. and Selexis SA Form Joint Scientific Advisory Board". Durham, NC & Geneva. 2018-12-03
CMS Hasche Sigle. (12/3/18). "Press Release: CMS berät Wellington und HBM als Lead Investoren der Serie D-Finanzierungsrunde der Adrenomed". München. 2018-12-03
GlaxoSmithKline plc. (12/3/18). "Press Release: GSK to Divest Horlicks and other Consumer Healthcare Nutrition Products to Unilever". 2018-12-03
SpinDiag GmbH. (12/3/18). "Press Release: SpinDiag Closes Second Financing Round of EUR 3.0 million (USD 3.4 million) to Complete Product Development of Its Point-of-Care Screening System for Antibiotic-resistant Bacteria". Freiburg. 2018-12-03
Qiagen N.V.. (11/30/18). "Press Release: Qiagen and NeoGenomics Collaborate to Offer Cancer Patients Day-One Access to Innovative Companion Diagnostics for Newly Approved Drugs". Hilden, Germantown, MD & Fort Myers, FL. 2018-11-30
MaSTherCell S.A.. (11/30/18). "Press Release: MaSTherCell Expands Production by Doubling Its Capacity". Gosselies. 2018-11-30
Marinomed Biotech AG. (11/29/18). "Press Release: Marinomed Suspends Offer Period of the Current IPO [Adhoc-News]". 2018-11-29
Biocartis Group N.V.. (11/29/18). "Press Release: Biocartis and AstraZeneca Enter into Agreement Aimed at Faster Lung Cancer Biomarker Results". Mechelen. 2018-11-29
Forbion Capital Partners. (11/29/18). "Press Release: Forbion Appoints Dr. Carlo Incerti as Operating Partner". Naarden & Munich. 2018-11-29
Polyplus-transfection S.A.. (11/29/18). "Press Release: Polyplus-transfection Launches a Powerful Nanotechnology for DNA Transfection Composed of jetOptimus Reagent". 2018-11-29
Qiagen N.V.. (11/28/18). "Press Release: Qiagen Extends Comprehensive Offering for Cervical Cancer Screening with European Launch of QIAscreen HPV PCR Test". Hilden. 2018-11-28
Marinomed Biotech AG. (11/28/18). "Press Release: Viennese Biotech Company Marinomed Demonstrates the Benefits of Its Patented Marinosolv Technology". 2018-11-28
Carbios S.A.. (11/28/18). "Press Release: Carbios and Kem One Sign a Letter of Intent to Implement a PET Biorecycling Demonstration Plant Operated by Carbios in the French Chemical Valley". Clermont-Ferrand. 2018-11-28
German Accelerator Life Sciences. (11/27/18). "Press Release: German Accelerator Life Sciences (GALS) Alumni Company SpinDiag Closes € 3M Funding Round". Freiburg & Cambridge, MA. 2018-11-27
Galapagos N.V.. (11/27/18). "Press Release: Galapagos Receives Fast Track Designation from FDA for GLPG1972/S201086 in Osteoarthritis". Mechelen. 2018-11-27
Inkef Capital. (11/27/18). "Press Release: Inkef Capital Appoints Roel Bulthuis as Managing Director to Co-Manage Eur 500m Fund". Amsterdam. 2018-11-27
BRAIN AG. (11/26/18). "Press Release: Suntory Beverage & Food Europe and BRAIN AG Start Joint Development Program". Zwingenberg & Uxbridge. 2018-11-26
Adrenomed AG. (11/26/18). "Press Release: Adrenomed Closes EUR 24 M Financing Led by Wellington and HBM". Hennigsdorf, Munich & Zug. 2018-11-26
Cyclica Inc.. (11/26/18). "Press Release: Cyclica Drives Drug Discovery through AI-Augmented Integrated Network of Cloud-Based Technologies together with Bayer". Toronto. 2018-11-26
Eurofins Scientific. (11/26/18). "Press Release: Eurofins Further Reduces Its Financing Costs after Redeeming Its EUR 300m November 2018 Eurobond and Extends Its Organic Growth Objectives beyond 2020". 2018-11-26
MorphoSys AG. (11/26/18). "Press Release: MorphoSys Announces Approval of Tremfya (Guselkumab) in Japan for the Treatment of Patients with Palmoplantar Pustulosis". Planegg. 2018-11-26
Curetis N.V.. (11/23/18). "Press Release: Curetis Announces Financial Results for the First Nine Months of 2018". Amsterdam, Holzgerlingen & San Diego, CA. 2018-11-23
Merck KGaA. (11/23/18). "Press Release: Merck Appoints Jasper Bos as Managing Director of M Ventures". Darmstadt. 2018-11-23
Spark Therapeutics, Inc.. (11/23/18). "Press Release: European Commission Approves Spark Therapeutics’ Luxturna (voretigene neparvovec), a One-time Gene Therapy for Inherited Retinal Disease Caused by Confirmed Biallelic RPE65 Mutations". Philadeliphia, 2018-11-23
Novadiscovery. (11/22/18). "Press Release: Novadiscovery Welcomes Two New Members to Its Team to Strengthen Its Combined Expertise in Artificial Intelligence and Clinical Medicine". Lyon. 2018-11-22
F2G Ltd.. (11/22/18). "Press Release: EU Supports F2G Biotech in Austria with EUR 24 Million for Antifungal Research and Innovation". Luxembourg. 2018-11-22
Santhera Pharmaceuticals Holding AG. (11/21/18). "Press Release: Santhera Calls Extraordinary General Meeting and Proposes Ordinary Share Capital Increase to Raise Approximately CHF 50 Million". Pratteln & Allschwil. 2018-11-21
InflaRx N.V.. (11/21/18). "Press Release: InflaRx N.V. Reports Third Quarter 2018 Financial & Operating Results". Jena. 2018-11-21
Evotec AG. (11/21/18). "Press Release: Evotec and Immuneering to Collaborate on Artifical Intelligence (“AI”) Driven Ligand Identification for Rare Hereditary Metabolic Diseases". Hamburg & Cambridge, MA. 2018-11-21
Santhera Pharmaceuticals Holding AG. (11/21/18). "Press Release: Santhera Enters into Agreement to Acquire Option from Idorsia for Exclusive Sub-License of First-in-class Dissociative Steroid Vamorolone". Pratteln & Allschwil. 2018-11-21
BRAIN AG. (11/21/18). "Press Release: Manfred Bender Set to Join BRAIN AG’s Management Board as Chief Financial Officer (CFO)". Zwingenberg. 2018-11-21
Celyad S.A.. (11/21/18). "Press Release: Celyad Announces Third Quarter 2018 Business Update". Mont-Saint-Guibert. 2018-11-21
Stilla Technologies S.A.S.. (11/20/18). "Press Release: Stilla Technologies Completes €16 Million ($18 Million) Series A". Paris. 2018-11-20
3B Pharmaceuticals GmbH. (11/20/18). "Press Release: Ipsen and 3BP Announce First Patient Dosed in Phase I/II Study for First-in-class Radionuclide (IPN01087)". Paris. 2018-11-20
Merck KGaA. (11/19/18). "Press Release: Merck and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer [Not intended for US, Canada and UK-based media]". Darmstadt. 2018-11-19
Merck KGaA. (11/19/18). "Press Release: Syntropy to Unlock the Value of Scientific Data in Fight to End Cancer. Joint Venture between Merck and Palantir Technologies Being Created to Advance Cancer Research". Palo Alto, CA. 2018-11-19
Marinomed Biotech AG. (11/16/18). "Press Release: Marinomed Determines IPO Timeline and Terms [Adhoc-News]". 2018-11-16
Centogene AG. (11/16/18). "Press Release: Centogene Announces CentoPharma, World’s First Platform for Targeted Patient Cohort Identification". Rostock. 2018-11-16
Noxxon Pharma N.V.. (11/16/18). "Press Release: Noxxon Announces € 6.2 Million Equity Capital Raise including US$ 5 Million from US Family Office – Acuitas Capital, LLC. Noxxon Ends the Use of Variable Rate Equity Financing with Yorkville". Berlin. 2018-11-16
Mologen AG. (11/16/18). "Press Release: Mologen AG to Retain Rights to Lefitolimod – Termination of Negotiations with Oncologie Inc. and Assessment of All Strategic Options in the Light of a Likely Read-out of the Pivotal Phase III IMPALA Trial in 2019". 2018-11-16
Apceth Biopharma GmbH. (11/16/18). "Press Release: Apceth Biopharma GmbH Manufactures DCprime’s Cell-based Cancer Vaccine for Phase II Clinical Study". Munich. 2018-11-16
MorphoSys AG. (11/15/18). "Press Release: MorphoSys and I-Mab Sign Strategic Partnering Agreement for MorphoSys's Novel Immuno-Oncology Agent MOR210". Planegg. 2018-11-15
Ipsen S.A.. (11/15/18). "Press Release: European Commission Approves Ipsen’s Cabometyx (cabozantinib) for the Treatment of Hepatocellular Carcinoma in Adults Previously Treated with Sorafenib". Paris. 2018-11-15
NBE Therapeutics AG. (11/15/18). "Press Release: Dr. Anthony Tolcher Joins the Scientific Advisory Board of NBE Therapeutics". Basel. 2018-11-15
Boehringer Ingelheim. (11/15/18). "Press Release: Boehringer Ingelheim and Epizyme Announce Worldwide Collaboration to Develop Novel Epigenetic Oncology Therapies". Cambridge, MA & Ingelheim. 2018-11-15
Lonza Group Ltd.. (11/15/18). "Press Release: Lonza and Sartorius Stedim Biotech Modify Relationship for Supply of Cell Culture Media". Basel & Aubagne. 2018-11-15
Bruker Corporation. (11/14/18). "Press Release: Bruker Announces Agreement for the Acquisition of Alicona Imaging GmbH". Billerica. 2018-11-14
Evotec AG. (11/13/18). "Press Release: Evotec AG Reports First Nine-months 2018 Results and Corporate Updates". Hamburg. 2018-11-13
Roivant Sciences GmbH. (11/13/18). "Press Release: Roivant Sciences Announces $200 Million Investment Round". Basel & London. 2018-11-13
IntegraGen S.A.. (11/12/18). "Press Release: IntegraGen Announces Collaboration with Google Cloud to Offer Large Scale Genomic Analysis Tools for Clinicians and Medical Researchers". Paris. 2018-11-12
Mologen AG. (11/12/18). "Press Release: Lefitolimod – First Clinical Data in Combination with a Checkpoint Inhibitor and further Preclinical Results Presented at SITC 2018". Berlin. 2018-11-12
Aimmune Therapeutics, Inc.. (11/12/18). "Press Release: Aimmune Therapeutics Announces Additional Equity Investment by Nestlé Health Science". Brisbane, CA. 2018-11-12
Quantum Genomics S.A.. (11/12/18). "Press Release: Quantum Genomics Announces Excellent Topline Results from Phase 2b NEW-HOPE Study Evaluating Firibastat for Arterial Hypertension". Paris & New York, NY. 2018-11-12
Life Sciences Partners (LSP). (11/12/18). "Press Release: LSP Raises Record €750 Million in 10 Months for Life Sciences Innovations [NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY JURISDICTION WHERE U 2018-11-12
Merck KGaA. (11/12/18). "Press Release: Merck Paves the Way for Its Innovation Hub in Southern China". Darmstadt & Guangzhou. 2018-11-12
Medigene AG. (11/12/18). "Press Release: Medigene Signs Exclusive License Agreement with Leiden University to Develop Novel T Cell Receptor". Martinsried. 2018-11-12
Medigene AG. (11/12/18). "Press Release: Medigene Reports Financial & Business Results for the First Nine Months of 2018". Planegg. 2018-11-12
Amal Therapeutics S.A.. (11/12/18). "Press Release: Amal Therapeutics Finalises €29 Million (CHF 33.2 Million) Series B Round". Geneva. 2018-11-12
bioMérieux S.A.. (11/9/18). "Press Release: bioMérieux Acquires a Majority Stake in Hybiome and Strengthens Its Presence Both in China and in the Immunoassay Market". Marcy l’Étoile. 2018-11-09
CRISPR Therapeutics AG. (11/9/18). "Press Release: CRISPR Therapeutics and MaxCyte Expand Clinical and Commercial License Agreement into Oncology". Zug, Cambridge, MA & Gaithersburg, MD. 2018-11-09
Scienion AG. (11/9/18). "Press Release: R2R Biofluidics EU Project Recently Received the Austrian Fast Forward Award 2018". Berlin. 2018-11-09
Mologen AG. (11/8/18). "Press Release: Implementation of Financing Measures and Publication of Study Results". Berlin. 2018-11-08
Themis Bioscience N.V.. (11/8/18). "Press Release: Themis Bioscience Postpones Its Listing on Euronext Amsterdam [Not for United States, Canada, Australia or Japan or any other jurisdiction where unlawful]". Vienna. 2018-11-08
InflaRx N.V.. (11/8/18). "Press Release: InflaRx Completes Enrollment in Phase IIb Clinical Trial with Lead Candidate IFX-1 in Hidradenitis Suppurativa". Jena. 2018-11-08
Convert Pharmaceuticals S.A.. (11/8/18). "Press Release: Convert Pharmaceuticals Appoints Mariola Söhngen as New CEO". 2018-11-08
Edinburgh Molecular Imaging Ltd.. (11/8/18). "Press Release: Edinburgh Molecular Imaging Appoints Bernhard Sixt as New Chief Executive Officer". Edinburgh. 2018-11-08
Bone Therapeutics S.A.. (11/7/18). "Press Release: Bone Therapeutics Business Update for Third Quarter 2018". Gosselies. 2018-11-07
Compugen Ltd.. (11/7/18). "Press Release: Compugen Reports Third Quarter 2018 Results". Holon. 2018-11-07
CRISPR Therapeutics AG. (11/7/18). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2018 Financial Results". Zug & Cambridge, MA. 2018-11-07
Curetis N.V.. (11/7/18). "Press Release: Curetis Raises €8.9 Million through Private Placements [Not for United States, Australia, Canada, Japan or South Africa or any other Jurisdiction where unlawful]". Amsterdam, Holzgerlingen & San Diego, CA. 2018-11-07
ProBioGen AG. (11/6/18). "Press Release: ProBioGen Announces Successful Bispecific GlymaxX Development Project for Zymeworks". Berlin. 2018-11-06
Bone Therapeutics S.A.. (11/6/18). "Press Release: Bone Therapeutics Announces Conclusions from Interim Analysis of Phase III PREOB Study in Hip Osteonecrosis". Gosselies. 2018-11-06
Genedata AG. (11/6/18). "Press Release: Sartorius Stedim Cellca Licenses Genedata Bioprocess to Streamline Development Operations". Basel. 2018-11-06
Themis Bioscience GmbH. (11/5/18). "Press Release: Themis Bioscience Publishes Compelling Phase 2 Results for Lead Vaccine Candidate against Chikungunya Fever in The Lancet". Vienna. 2018-11-05
Immunic AG. (11/5/18). "Press Release: Immunic Enters into a Global Option and License Agreement with Daiichi Sankyo". Planegg-Martinsried. 2018-11-05
MorphoSys AG. (11/5/18). "Press Release: MorphoSys AG Announces Third Quarter 2018 Results". Planegg. 2018-11-05
Boehringer Ingelheim. (11/5/18). "Press Release: Initial Results from EMPRISE Real-world Evidence Study". Ingelheim & Indianapolis, IN. 2018-11-05
BioNTech AG. (11/5/18). "Press Release: BioNTech and the University of Pennsylvania Enter into Strategic Research Collaboration to Develop mRNA Vaccine Candidates against Various Infectious Diseases". Mainz. 2018-11-05
Marinomed Biotech AG. (11/5/18). "Press Release: Marinomed Announces Its Intention to Launch an Initial Public Offering and Listing on the Vienna Stock Exchange [Not for US, AU, CA, JP, et al.]". Vienna. 2018-11-05
Omeicos Therapeutics GmbH. (11/2/18). "Press Release: Omeicos Therapeutics Closes €17m Series C Financing to Advance Lead Candidate OMT-28 Towards Pivotal Trials in Atrial Fibrillation". Berlin & Boston, MA. 2018-11-02
Cristal Delivery B.V. (d/b/a Cristal Therapeutics). (11/2/18). "Press Release: Dr. Axel Mescheder Appointed CEO of Cristal Therapeutics as Focus Intensifies on Proprietary Oncology Nanomedicine Pipeline". Maastricht. 2018-11-02
Curetis N.V.. (11/2/18). "Press Release: Curetis Launches Privately Placed Capital Increase to Raise up to €18.4 Million [NOT FOR THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL]". Amsterdam, Hol 2018-11-02
Centogene AG. (11/2/18). "Press Release: Centogene Further Expands Executive Team, Appoints Oved Amitay as Chief Business Officer – Increases Focus on Pharma Partnerships". Rostock. 2018-11-02
Denali Therapeutics Inc.. (11/1/18). "Press Release: Denali Therapeutics Announces Broad Collaboration with Sanofi to Develop RIPK1 Inhibitors for the Treatment of Neurological and Inflammatory Diseases". South San Francisco, CA. 2018-11-01
1 2 3 ... 112 113 114  next pagenext page



Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top